The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

How AI-driven process optimization could lower costs and improve success rates in drug development.

How digital technology has, and will continue to, augment scientific data collection and discovery

Exploring the potential of leriglitazone in helping patients with cerebral X-linked adrenoleukodystrophy.

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.

Kristina Kempf at PTC Therapeutics discusses the importance of strong female role models.

We get more details on the ready-to-use technologies alliance forged between Schott Pharma, Gerresheimer, and Stevanato.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How CRISPR can change the way we design and produce antibodies.